Shigematsu Works Co., Ltd. (JP:7980)
:7980
Want to see JP:7980 full AI Analyst Report?
Top Page
Shigematsu Works Co., Ltd.
(7980)
Select Model
Select Model
Rating:82Outperform
Price Target:
¥971.00
▲(24.01% Upside)
Action:ReiteratedDate:03/10/26
The score is driven by strong technical uptrend signals and an attractive low P/E valuation. Financial performance is solid on revenue growth and margins with a stable balance sheet, but it is tempered by negative free cash flow and weak cash generation from operations.
Positive Factors
Recurring consumable revenue
Shigematsu's business includes recurring sales of filters, cartridges and replacement parts tied to compliance and replacement cycles. This creates predictable, repeatable revenue and higher lifetime customer value, supporting steady cash inflows and resilience to single-order volatility.
Negative Factors
Negative free cash flow
Despite accounting profits, weak cash conversion and -1.65B yen free cash flow reflect heavy capex and limited operating cash generation. Over months, this can constrain reinvestment, dividend policy or force external financing if capex remains high versus cash from operations.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring consumable revenue
Shigematsu's business includes recurring sales of filters, cartridges and replacement parts tied to compliance and replacement cycles. This creates predictable, repeatable revenue and higher lifetime customer value, supporting steady cash inflows and resilience to single-order volatility.
Read all positive factors
Shigematsu Works Co., Ltd. (7980) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥5.95B
Dividend Yield1.93%
Average Volume (3M)7.97K
Price to Earnings (P/E)6.1
Beta (1Y)0.07
Revenue Growth6.69%
EPS Growth1.67%
CountryJP
Employees386
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)93.64
Shares Outstanding7,200,000
10 Day Avg. Volume9,150
30 Day Avg. Volume7,966
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)0.67
Price to Sales (P/S)0.41
P/FCF Ratio-3.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Shigematsu Works Co., Ltd. Business Overview & Revenue Model
Company Description
Shigematsu Works Co., Ltd. manufactures and sells protective equipment in Japan. It offers protective clothing and gloves; eye protectors; reusable respirators; disposable respirators; powered air purifying respirators; supplied-air respirators; s...
How the Company Makes Money
Revenue is primarily generated from the sale of respiratory protective products to corporate and institutional customers. Key revenue streams typically include (1) sales of respiratory protective devices (e.g., masks/respirators) and (2) recurring...
Shigematsu Works Co., Ltd. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.08B | 14.11B | 13.00B | 12.88B | 11.92B | 12.70B |
| Gross Profit | 4.27B | 4.30B | 3.93B | 4.01B | 3.63B | 4.02B |
| EBITDA | 1.67B | 1.73B | 1.31B | 1.69B | 1.25B | 1.36B |
| Net Income | 665.87M | 780.58M | 584.08M | 748.24M | 589.11M | 651.05M |
Balance Sheet | ||||||
| Total Assets | 17.98B | 18.17B | 16.22B | 15.32B | 14.32B | 13.98B |
| Cash, Cash Equivalents and Short-Term Investments | 1.46B | 1.48B | 1.63B | 1.63B | 1.35B | 1.53B |
| Total Debt | 4.84B | 5.04B | 3.12B | 3.13B | 3.36B | 3.45B |
| Total Liabilities | 9.32B | 9.61B | 7.94B | 7.97B | 7.83B | 8.37B |
| Stockholders Equity | 8.66B | 8.57B | 8.28B | 7.35B | 6.50B | 5.62B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.65B | 399.81M | 667.73M | 26.94M | -328.40M |
| Operating Cash Flow | 0.00 | 228.18M | 966.39M | 1.12B | 490.66M | 762.84M |
| Investing Cash Flow | 0.00 | -2.21B | -838.81M | -643.92M | -496.46M | -1.13B |
| Financing Cash Flow | 0.00 | 1.83B | -125.72M | -299.93M | -173.66M | 399.23M |
Shigematsu Works Co., Ltd. Technical Analysis
Neutral
783.00
Price Trends
933.40
Negative
854.53
Positive
824.91
Positive
Market Momentum
-16.53
Positive
40.34
Neutral
4.11
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7980, the sentiment is Neutral. The current price of 783 is below the 20-day moving average (MA) of 928.42, below the 50-day MA of 933.40, and below the 200-day MA of 824.91, indicating a neutral trend. The MACD of -16.53 indicates Positive momentum. The RSI at 40.34 is Neutral, neither overbought nor oversold. The STOCH value of 4.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7980.
Shigematsu Works Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥5.95B | 6.06 | ― | 1.93% | 6.69% | 1.67% | |
71 Outperform | ¥168.07B | 20.62 | ― | 2.73% | 6.29% | -7.19% | |
68 Neutral | ¥861.24B | 24.33 | 11.64% | 0.82% | 13.17% | -1.27% | |
63 Neutral | ¥235.09B | -69.02 | -2.06% | 2.66% | 5.37% | -128.89% | |
62 Neutral | ¥243.10B | 5.59 | 4.38% | 2.03% | 4.10% | 199.63% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | ¥10.41B | 31.52 | ― | 3.85% | -5.44% | -288.95% |
* Healthcare Sector Average
JP:7980
Shigematsu Works Co., Ltd.
837.00
80.90
10.70%
JP:7747
Asahi Intecc Co
3,246.00
1,049.11
47.75%
JP:7716
Nakanishi
2,785.00
947.49
51.56%
JP:8086
Nipro
1,490.50
237.64
18.97%
JP:7702
JMS Co., Ltd.
426.00
-14.88
-3.37%
JP:7730
Mani, Inc.
1,706.00
556.55
48.42%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.